Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | VP, Global Clinical, Medical | May 10, 2021 | May 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date May 10, 2021 · Filed May 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,301 |
Ending reported balance
After 2021-05-10 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2021-05-10 · Sale · Disposed 1,349 · Balance 8,342 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive. Row 2 · 2021-05-10 · Exercise / conversion · Acquired 7,200 · Balance 15,542 Row 3 · 2021-05-10 · Exercise / conversion · Acquired 2,534 · Balance 18,076 Row 4 · 2021-05-10 · Exercise / conversion · Acquired 3,462 · Balance 21,538 Row 5 · 2021-05-10 · Exercise / conversion · Acquired 5,523 · Balance 27,061 Row 6 · 2021-05-10 · Sale · Disposed 10,760 · Balance 16,301 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive. |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $16.15 · Expires 2028-03-14 | Direct | 0 |
Reported balance
After 2021-05-10 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-05-10 · Exercise / conversion · Disposed 7,200 · Balance 0 F3: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028. |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $29.80 · Expires 2028-06-13 | Direct | 750 |
Reported balance
After 2021-05-10 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-05-10 · Exercise / conversion · Disposed 2,534 · Balance 750 F4: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028. |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $35.98 · Expires 2029-03-13 | Direct | 8,564 |
Reported balance
After 2021-05-10 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-05-10 · Exercise / conversion · Disposed 3,462 · Balance 8,564 F5: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $27.53 · Expires 2030-03-19 | Direct | 9,774 |
Reported balance
After 2021-05-10 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-05-10 · Exercise / conversion · Disposed 5,523 · Balance 9,774 F6: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive.
F3: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028.
F4: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028.
F5: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
F6: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 5,523 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 10 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,774 Underlying: Common Stock · 5,523 shares Expires 2030-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 3,462 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 9 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,564 Underlying: Common Stock · 3,462 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 2,534 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 8 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 2,534 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 7,200 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · derivative · entry 7 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,200 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 10,760 | $124.13 | $1,335,638.80 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 6 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,301 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,523 | $27.53 | $152,048.19 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 3,462 | $35.98 | $124,562.76 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 2,534 | $29.80 | $75,513.20 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 7,200 | $16.15 | $116,280.00 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 1,349 | $125.22 | $168,921.78 |
DisclosureSEC source: 0001209191-21-032101 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,342 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive. Read SEC document |
| March 22, 2021 Filed Mar 22, 2021 23:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 1,103 | $96.37 | $106,296.11 |
DisclosureSEC source: 0001209191-21-022444 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,691 Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:15 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 9,759 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020521 · doc4.xml · derivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,759 Underlying: Common Stock · 9,759 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:37 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 16,000 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-016886 · doc4.xml · derivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,026 Underlying: Common Stock · 16,000 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:37 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 16,000 | $105.43 | $1,686,880.00 |
DisclosureSEC source: 0001209191-21-016886 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.86 to $106.19, inclusive. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:37 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 16,000 | $35.98 | $575,680.00 |
DisclosureSEC source: 0001209191-21-016886 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 9,800 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · derivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724 Underlying: Common Stock · 9,800 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 10,200 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · derivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,058 Underlying: Common Stock · 10,200 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 20,000 | $81.34 | $1,626,800.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.06 to $82.85, inclusive. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 9,800 | $16.15 | $158,270.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:51 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 10,200 | $29.80 | $303,960.00 |
DisclosureSEC source: 0001209191-20-057990 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 8,000 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 9 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,476 Underlying: Common Stock · 8,000 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 11,574 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 8 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,574 shares Expires 2025-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 5,822 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 7 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,822 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 16,206 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 6 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,206 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 41,602 | $51.22 | $2,130,854.44 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.20 to $53.10, inclusive. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 8,000 | $16.15 | $129,200.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 11,574 | $8.64 | $99,999.36 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,822 | $7.52 | $43,781.44 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 16,206 | $9.30 | $150,715.80 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 6,091 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · derivative · entry 7 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 6,091 shares Expires 2025-07-26 Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 19,178 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · derivative · entry 6 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,822 Underlying: Common Stock · 19,178 shares Expires 2026-03-17 Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 21,294 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · derivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,206 Underlying: Common Stock · 21,294 shares Expires 2027-03-20 Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 46,563 | $39.11 | $1,821,078.93 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.89 to $39.10, inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 6,091 | $8.64 | $52,626.24 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 19,178 | $7.52 | $144,218.56 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 21,294 | $9.30 | $198,034.20 |
DisclosureSEC source: 0001209191-20-028980 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 2,813 | $26.83 | $75,472.79 |
DisclosureSEC source: 0001209191-20-020928 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.07 to $27.49, inclusive. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 15,297 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001209191-20-020928 · doc4.xml · derivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,297 Underlying: Common Stock · 15,297 shares Expires 2030-03-19 F3 · security: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:18 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 7,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020928 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,607 F1 · security: Award of 7357 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 32,335 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · derivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,665 Underlying: Common Stock Options · 32,335 shares Expires 2025-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three equal installments on July 27, 2016, July 27, 2017, and July 27, 2018. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 15,073 | $37.31 | $562,373.63 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.55, inclusive. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 32,335 | $37.15 | $1,201,245.25 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,323 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.33, inclusive. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 32,335 | $8.64 | $279,374.40 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.